Figures & data
Notes: Success, no treatment or follow-up necessary, leading to intended gap >56 days; continuous adherence, patient underwent frequent treatments or follow-ups at least every 56 days; nonadherence, at least one unintended gap >56 days between treatments or follow-ups; this subgroup is further analyzed in .
Abbreviations: nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion.
Abbreviations: nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion.
Notes: Patient, patient-associated NA; center, center-associated NA; inactive, no treatment necessary at last visit before NA; active, treatment intended at last visit before NA.
Abbreviations: nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion; NA, nonadherence.
Abbreviations: nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion; NA, nonadherence.
Note:
p=0.014 between groups, log-rank test.
Abbreviations: NA, nonadherence; nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion.
Abbreviations: NA, nonadherence; nAMD, neovascular age-related macular degeneration; DME, diabetic macular edema; BRVO, branch retinal vein occlusion.